Remote delivery of cognitive behavioral therapy for high-impact chronic pain produced modest but sustained improvements in ...

The FDA has approved a medical device that stimulates the vagus nerve for the treatment of moderate-to-severe rheumatoid arthritis (RA) in patients who have not responded to — or cannot tolerate — ...

The FDA has approved the SetPoint System, a vagus nerve stimulator from SetPoint Medical, for the treatment of rheumatoid ...

The SetPoint System consists of a neurostimulation device that is surgically placed under general anesthesia on the vagus nerve.

The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease.

SetPoint Medical announced today that the FDA approved its SetPoint neuroimmune modulation system for treating rheumatoid ...

Stepping into a virtual forest or waterfall scene through VR could be the future of pain management. A new study shows that ...

The rate of ER opioid prescriptions for back pain fell by more than half between 2016 and 2022, researchers reported July 12 in the Annals of Emergency Medicine.

Ensysce Biosciences Initiates Pivotal Phase 3 Study of PF614 - A Next-Generation Opioid - Designed to Deliver Powerful Pain Relief and Reduce Abuse ~ FDA Protocol Review Completed ~ ~ Rho, Inc.

Summer marks the ideal opportunity for travel and relaxation, allowing individuals to plan their perfect getaway. However, for those who struggle with chronic joint pain, increased travel and outdoor ...

Senator Richard Blumenthal grilled Secretary Kristi Noem during her Senate confirmation hearing, exposing her plan to politicize disaster relief upon taking office.